{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:07:49Z","timestamp":1792681669895,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004321","name":"Shire Pharmaceuticals","doi-asserted-by":"publisher","award":["SHP634-402"],"award-info":[{"award-number":["SHP634-402"]}],"id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ecl.2018.07.008","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:18:52Z","timestamp":1541074732000},"page":"825-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Skeletal Manifestations of Hypoparathyroidism"],"prefix":"10.1016","volume":"47","author":[{"given":"Mishaela R.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2018.07.008_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2018.07.008_bib2","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib3","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib4","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib5","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib6","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib7","first-page":"2135","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI110570","article-title":"Differential effects of endocrine dysfunction on the axial and the appendicular skeleton","volume":"69","author":"Seeman","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2018.07.008_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","article-title":"Hypoparathyroidism counteracts risk factors for osteoporosis","volume":"310","author":"Touliatos","year":"1995","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ecl.2018.07.008_bib10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib11","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00441552","article-title":"Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment","volume":"148","author":"Kruse","year":"1989","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ecl.2018.07.008_bib14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1172\/JCI113690","article-title":"Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism","volume":"82","author":"Mizunashi","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2018.07.008_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/jc.2009-2682","article-title":"Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism","volume":"96","author":"Rubin","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib16","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1210\/jc.2011-0566","article-title":"Circulating sclerostin in disorders of parathyroid gland function","volume":"96","author":"Costa","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem.84.2.5498","article-title":"Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone","volume":"84","author":"Duan","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1210\/endo-119-3-1298","article-title":"1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs","volume":"119","author":"Malluche","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2018.07.008_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone"},{"issue":"supp 21","key":"10.1016\/j.ecl.2018.07.008_bib21","first-page":"1135","article-title":"Indices of bone quality are markedly abnormal in hypoparathyroidism","author":"Rubin","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib23","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.ecl.2018.07.008_bib24","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Post-surgical hypoparathyroidism - risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib25","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib26","first-page":"251","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","article-title":"Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy","volume":"21","author":"Cohen","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2018.07.008_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib29","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective six year investigation of efficacy and safety","volume":"101","author":"Rubin","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib30","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ecl.2018.07.008_bib32","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2018.07.008_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A\u00a0novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib34","unstructured":"Long-term administration of rhPTH(1-84) results in marked and sustained improvements in skeletal indices by bone histomorphometry in hypoparathyroidism 2017. Available at: http:\/\/www.asbmr.org\/education\/AbstractDetail?aid=0f96a6c1-6c8b-4af6-b8e3-ff9d3cec2b00. Accessed February 25, 2018."},{"key":"10.1016\/j.ecl.2018.07.008_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jbmr.2777","article-title":"Effects of parathyroid hormone administration on bone strength in hypoparathyroidism","volume":"31","author":"Rubin","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jbmr.2588","article-title":"PTH(1-84) administration in hypoparathyroidism transiently reduces bone matrix mineralization","volume":"31","author":"Misof","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2131\/jts.37.617","article-title":"Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34))","volume":"37","author":"Watanabe","year":"2012","journal-title":"J\u00a0Toxicol Sci"},{"key":"10.1016\/j.ecl.2018.07.008_bib38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ecl.2018.07.008_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.ecl.2018.07.008_bib40","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A\u00a010-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2018.07.008_bib41","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918305425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918305425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:59Z","timestamp":1760175899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852918305425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0889852918305425"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2018.07.008","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Manifestations of Hypoparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2018.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}